Filters

School-based salt education programme in China lowers blood pressure and offers huge potential for scale-up

A school-based salt education programme in China has worked with families, teachers and health educators to raise awareness about the risks of excess salt consumption and encourage people to reduce salt use in cooking. ‘EduSaltS’ reduced salt consumption and blood pressure in family members of the primary school children involved and is the first large-scale salt education programme to show such significant results. The approach is now being piloted in districts in Beijing and serves as a model which could be scaled up in China and other countries to help tackle cardiovascular disease – the biggest global killer. Excessive salt intake is the leading dietary risk factor for premature death and disability in China, with 80% of dietary salt added during cooking. A high-salt diet is associated with raised blood pressure, which increases the risk of cardiovascular diseases (such as heart attacks and stroke), the leading cause of death in low- and middle-income countries. The EduS

Putting the consumer first: Creating a consumer-centred health system for a 21st Century Australia

Policy & Practice Report

Australia-China healthcare opportunities

Policy & Practice Report

Women's Health: A new global agenda

Policy & Practice Report

mobile + health = boosting China’s healthcare bandwidth

Policy & Practice Report

Australian Medical Research and Innovation Strategy

Policy & Practice Report

Patient-Centred Healthcare Homes in Australia: Towards Successful Implementation report

Policy & Practice Report

Data Availability and Use Inquiry

Policy & Practice Report

Framing women’s health issues in 21st century India

Policy & Practice Report

The Breathlessness Rapid Evaluation And THErapy study (BREATHE)

Background:About 1 in 10 adults have breathlessness, totalling over 1.8 million in Australia alone.Breathlessness (dyspnoea) is a common presenting complaint in primary care and is a symptom of cardiovascular and respiratory disease, but also associated with obesity, loss of fitness and anxiety.Breathlessness that chronically limits exertion significantly reduces quality of life and is becoming more prevalent following bushfires, consequent worsening air pollution and severe SARS-CoV-2 pandemic. Respiratory conditions account for around 10% of deaths in Australia and 31% of Australian adults have a chronic respiratory disease. There is a significant need to improve health outcomes in respiratory space, however the multifactorial nature of breathlessness challenges general practitioners’ ability to provide correct diagnosis or best management. In a recent survey of over 10,000 Australian adults, 22% reported a current respiratory or heart condition or both. Of those with a current respiratory condi

Impact: George Institute study on occupational health hazards among ‘bidi’ workers informs WHO policy brief

Policy & Practice Report

carDIovaScular and renal outCOmes in patients recoVERed from AKI (DISCOVER)

BackgroundAcute kidney injury (AKI) is caused by a loss of kidney function. This leaves the body unable to remove waste products, and balance water and electrolyte levels effectively. Some people with AKI may experience it short-term and recover their kidney function. For others, AKI may progress further and develop into chronic kidney disease (CKD), especially for those who have other co-existing conditions that require treatment. People who have recovered from AKI, however, have an increased risk of other health problems or even having AKI again in the future.A new class of oral anti-hyperglycaemic drugs, called sodium glucose co-transporter 2 (SGLT2) inhibitors, were initially used in the treatment of T2DM. They work by increasing the removal of glucose, and in turn lowering blood glucose levels.There is now a growing amount of research evidence to show SGLT2 inhibitors have additional benefits in people who are at risk of cardiovascular and kidney disease. SGLT2 inhibitors have been shown t